203 related articles for article (PubMed ID: 21457078)
1. Cationic phospholiposomes: efficient delivery vehicles of anticancer derivatives of ATP to multiple myeloma cells.
Wang L; MacDonald RC
J Liposome Res; 2011 Dec; 21(4):306-14. PubMed ID: 21457078
[TBL] [Abstract][Full Text] [Related]
2. Surface properties of dioleoyl-sn-glycerol-3-ethylphosphocholine, a cationic phosphatidylcholine transfection agent, alone and in combination with lipids or DNA.
Macdonald RC; Gorbonos A; Momsen MM; Brockman HL
Langmuir; 2006 Mar; 22(6):2770-9. PubMed ID: 16519481
[TBL] [Abstract][Full Text] [Related]
3. Layersome: development and optimization of stable liposomes as drug delivery system.
Ciobanu M; Heurtault B; Schultz P; Ruhlmann C; Muller CD; Frisch B
Int J Pharm; 2007 Nov; 344(1-2):154-7. PubMed ID: 17616287
[TBL] [Abstract][Full Text] [Related]
4. Factors governing the assembly of cationic phospholipid-DNA complexes.
Kennedy MT; Pozharski EV; Rakhmanova VA; MacDonald RC
Biophys J; 2000 Mar; 78(3):1620-33. PubMed ID: 10692346
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics.
Deniz A; Sade A; Severcan F; Keskin D; Tezcaner A; Banerjee S
Biosci Rep; 2010 Jun; 30(5):365-73. PubMed ID: 19900165
[TBL] [Abstract][Full Text] [Related]
6. Electrostatically mediated interactions between cationic lipid-DNA particles and an anionic surface.
Wong FM; Bally MB; Brooks DE
Arch Biochem Biophys; 1999 Jun; 366(1):31-9. PubMed ID: 10334860
[TBL] [Abstract][Full Text] [Related]
7. Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug.
Shim G; Han SE; Yu YH; Lee S; Lee HY; Kim K; Kwon IC; Park TG; Kim YB; Choi YS; Kim CW; Oh YK
J Control Release; 2011 Oct; 155(1):60-6. PubMed ID: 20971142
[TBL] [Abstract][Full Text] [Related]
8. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of vinblastine into transfersomes and liposomes in response to a transmembrane ammonium sulfate gradient and their cytotoxic/cytostatic activity in vitro.
Maswadeh H; Demetzos C; Dimas K; Hatziantoniou S; Georgopoulos A; Rallis M; Dallas P; Papaioannou G
Anticancer Res; 2001; 21(4A):2577-83. PubMed ID: 11724324
[TBL] [Abstract][Full Text] [Related]
10. Studies on the Interactions of 2-Hydroxyoleic Acid with Monolayers and Bilayers Containing Cationic Lipid: Searching for the Formulations for More Efficient Drug Delivery to Cancer Cells.
Olechowska K; Mach M; Ha C-Wydro K; Wydro P
Langmuir; 2019 Jul; 35(27):9084-9092. PubMed ID: 31246038
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation enhancement and stabilization of insulin in cationic liposomes.
Park SJ; Choi SG; Davaa E; Park JS
Int J Pharm; 2011 Aug; 415(1-2):267-72. PubMed ID: 21645598
[TBL] [Abstract][Full Text] [Related]
12. A hydroxyethylated cholesterol-based cationic lipid for DNA delivery: effect of conditioning.
Percot A; Briane D; Coudert R; Reynier P; Bouchemal N; Lièvre N; Hantz E; Salzmann JL; Cao A
Int J Pharm; 2004 Jun; 278(1):143-63. PubMed ID: 15158957
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of cationic liposomes and its role in enhancing cellular uptake of antisense oligonucleotides].
Chen HL; Liang WQ; Shao JB; Chen Z
Yao Xue Xue Bao; 2004 Jan; 39(1):72-6. PubMed ID: 15127587
[TBL] [Abstract][Full Text] [Related]
14. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
15. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
16. Polyethylenimine modified liposomes as potential carriers for antitumor drug delivery in vitro.
Sun X; Chen J; Chen H; Liang W
Pharmazie; 2012 May; 67(5):426-31. PubMed ID: 22764577
[TBL] [Abstract][Full Text] [Related]
17. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting microencapsulation of drugs in liposomes.
Kulkarni SB; Betageri GV; Singh M
J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
[TBL] [Abstract][Full Text] [Related]
19. Pilocarpine hydrochloride liposomes: characterization in vitro and preliminary evaluation in vivo in rabbit eye.
Benita S; Plenecassagne JD; Cavé G; Drouin D; Le Hao Dong P; Sincholle D
J Microencapsul; 1984; 1(3):203-16. PubMed ID: 6336525
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes.
Abraham SA; Edwards K; Karlsson G; Hudon N; Mayer LD; Bally MB
J Control Release; 2004 May; 96(3):449-61. PubMed ID: 15120901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
